In The News: Kirk Kerkorian School of Medicine at UNLV

Cutting-edge research involving tiny lab-grown cell clusters known as ‘organoids’ are providing breakthroughs in brain research at UNLV.

As the Las Vegas Raiders prepare to face the San Francisco 49ers, brain health remains an important topic in football.

One UNLV doctor and professor is applauding the breakthrough results as a personalized mRNA cancer vaccine has shown promise for preventing recurrence of melanoma, according to a new trial from drugmakers Merck and Moderna.
Biogen is pushing its experimental Alzheimer’s drug diranersen into Phase 3 trials despite missing the primary dose-response goal in its 416-patient CELIA study, after the lowest tested dose paradoxically delivered the strongest results—slowing cognitive decline on the CDR-SB scale by 26% over 18 months.

A neonatal intensive care unit that serves some of the region’s most vulnerable newborns is set to close in Henderson, reducing the number of NICUs available in Clark County.

A UNLV professor and doctor is explaining what he says will be the long-term impact of President Donald Trump's executive order on childhood vaccine recommendations.
Even small amounts of physical activity may help reduce the risk of stroke and premature death among people with atrial fibrillation (AFib), new research suggests.

Getting your kids back into their school routines can yield profound benefits. But it can also reveal underlying challenges.

Getting your kids back into their school routines can yield profound benefits. But it can also reveal underlying challenges.

A UNLV professor and doctor is weighing in on the science behind the pandemic, as partisan politics are playing out in Washington.

Every summer, hospitals across Clark County treat patients from all walks of life whose bodies can no longer cope with the extreme heat.

Serenity, balance, calm: All are sensible but often-challenging intentions during our demanding and stressful days.